相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。PKM2 Modulation in Head and Neck Squamous Cell Carcinoma
Verena Boschert et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
ATAD3A mediates activation of RAS-independent mitochondrial ERK1/2 signaling, favoring head and neck cancer development
Liwei Lang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation
Guangping Zhang et al.
CANCER BIOLOGY & THERAPY (2022)
The Quest to Eradicate HPV-Related Oropharyngeal Carcinoma: An Opportunity Not to Miss
Chloe S. Lalonde et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)
ENO1 and Cancer
Chen Kai Huang et al.
MOLECULAR THERAPY-ONCOLYTICS (2022)
A Novel Enolase-1 Antibody Targets Multiple Interacting Players in the Tumor Microenvironment of Advanced Prostate Cancer
Mao-Lin Chen et al.
MOLECULAR CANCER THERAPEUTICS (2022)
ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1
Tong Zhang et al.
NATURE CANCER (2022)
Activator-Mediated Pyruvate Kinase M2 Activation Contributes to Endotoxin Tolerance by Promoting Mitochondrial Biogenesis
Zhujun Yi et al.
FRONTIERS IN IMMUNOLOGY (2021)
Blockade of glutamine-dependent cell survival augments antitumor efficacy of CPI-613 in head and neck cancer
Liwei Lang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
The Hidden Link of Exosomes to Head and Neck Cancer
Yong Teng et al.
CANCERS (2021)
Head and neck cancer
Mayur D. Mody et al.
LANCET (2021)
Specific Pyruvate Kinase M2 Inhibitor, Compound 3K, Induces Autophagic Cell Death through Disruption of the Glycolysis Pathway in Ovarian Cancer Cells
Jae Hyeon Park et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting Tumorigenesis
Kulsoom Zahra et al.
FRONTIERS IN ONCOLOGY (2020)
Targeting Hypoxia-Driven Metabolic Reprogramming to Constrain Tumor Progression and Metastasis
Marisol Miranda-Galvis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Metabolic landscape of oral squamous cell carcinoma
Jessica Gardone Vitorio et al.
METABOLOMICS (2020)
Enolase 1 regulates stem cell-like properties in gastric cancer cells by stimulating glycolysis
Ting Yang et al.
CELL DEATH & DISEASE (2020)
Head and neck squamous cell carcinoma
Daniel E. Johnson et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
An enolase inhibitor for the targeted treatment of ENO1-deleted cancers
Yu-Hsi Lin et al.
NATURE METABOLISM (2020)
Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer
Yan Zheng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Intracellular citrate accumulation by oxidized ATM-mediated metabolism reprogramming via PFKP and CS enhances hypoxic breast cancer cell invasion and metastasis
Meixi Peng et al.
CELL DEATH & DISEASE (2019)
FGF19 amplification reveals an oncogenic dependency upon autocrine FGF19/FGFR4 signaling in head and neck squamous cell carcinoma
Lixia Gao et al.
ONCOGENE (2019)
ENO2 Promotes Cell Proliferation, Glycolysis, and Glucocorticoid-Resistance in Acute Lymphoblastic Leukemia
Cheng-cheng Liu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Autophagy blockade sensitizes human head and neck squamous cell carcinoma towards CYT997 through enhancing excessively high reactive oxygen species-induced apoptosis
Lixia Gao et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2018)
Pyruvate kinase M2 fuels multiple aspects of cancer cells: from cellular metabolism, transcriptional regulation to extracellular signaling
Ming-Chuan Hsu et al.
MOLECULAR CANCER (2018)
Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival
Gaurav Pathria et al.
EMBO JOURNAL (2018)
FGFR4 provides the conduit to facilitate FGF19 signaling in breast cancer progression
Xiangdong Zhao et al.
MOLECULAR CARCINOGENESIS (2018)
ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes
Haaglim Cho et al.
SCIENTIFIC REPORTS (2017)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
PKM2, cancer metabolism, and the road ahead
Talya L. Dayton et al.
EMBO REPORTS (2016)
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
Tanguy Y. Seiwert et al.
LANCET ONCOLOGY (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V. Liberti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
PKM2 and cancer: The function of PKM2 beyond glycolysis
Gaochao Dong et al.
ONCOLOGY LETTERS (2016)
ENOblock Does Not Inhibit the Activity of the Glycolytic Enzyme Enolase
Nikunj Satani et al.
PLOS ONE (2016)
IGF1 regulates PKM2 function through Akt phosphorylation
Barbara Salani et al.
CELL CYCLE (2015)
The Correlations Between MRI Perfusion, Diffusion Parameters, and 18F-FDG PET Metabolic Parameters in Primary Head-and-Neck Cancer A Cross-Sectional Analysis in Single Institute
Miran Han et al.
MEDICINE (2015)
Pyruvate kinase: Function, regulation and role in cancer
William J. Israelsen et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop
Wenkang Luan et al.
ONCOTARGET (2015)
High glucose uptake unexpectedly is accompanied by high levels of the mitochondrial β-F1-ATPase subunit in head and neck squamous cell carcinoma
Christian U. Huebbers et al.
ONCOTARGET (2015)
A Unique Small Molecule Inhibitor of Enolase Clarifies Its Role in Fundamental Biological Processes
Da-Woon Jung et al.
ACS CHEMICAL BIOLOGY (2013)
PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and Tumorigenesis
Weiwei Yang et al.
CELL (2012)
Altered metabolism in head and neck squamous cell carcinoma: an opportunity for identification of novel biomarkers and drug targets
Vlad C. Sandulache et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2012)
ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect
Weiwei Yang et al.
NATURE CELL BIOLOGY (2012)
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
Dimitrios Anastasiou et al.
NATURE CHEMICAL BIOLOGY (2012)
Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
Weiwei Yang et al.
NATURE (2011)
Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2
J. Chen et al.
ONCOGENE (2011)
EGF-Induced ERK Activation Promotes CK2-Mediated Disassociation of α-Catenin from β-Catenin and Transactivation of β-Catenin
Haitao Ji et al.
MOLECULAR CELL (2009)
Pyruvate kinase M2 is a phosphotyrosine-binding protein
Heather R. Christofk et al.
NATURE (2008)
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Heather R. Christofk et al.
NATURE (2008)
The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention
John P. Alao
MOLECULAR CANCER (2007)